LFCR - Lifecore Biomedical - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart

LFCR is currently covered by 2 analysts with an average price target of $7.75. This is a potential upside of $1.36 (21.28%) from yesterday's end of day stock price of $6.39.

Lifecore Biomedical's activity chart (see below) currently has 18 price targets and 20 ratings on display. The stock rating distribution of LFCR is 83.33% BUY and 16.67% HOLD.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 66.02% of the time, taking 132.83 days on average.

Highest price target for LFCR is $9, Lowest price target is $6.5, average price target is $7.75.

Most recent stock forecast was given by MICHAEL PETUSKY from BARRINGTON on 28-Sep-2026. First documented stock forecast 10-Jan-2023.

Best performing analysts who are covering LFCR - Lifecore Biomedical:

Michael Petusky Jacob Johnson Matt Hewitt

Currently out of the existing stock ratings of LFCR, 1 are a HOLD (16.67%), 5 are a BUY (83.33%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 23-Mar-2026

$6.5

1 months 23 days ago
(28-Sep-2026)

7/9 (77.78%)

$1.15 (21.50%)

102

Buy Since 04-Sep-2024

$9

$2.61 (40.85%)

$10

8 months 4 days ago
(16-Mar-2026)

1/3 (33.33%)

$4.64 (106.42%)

292

Hold Since 02-Apr-2024

$6

$6

1 years 10 months 18 days ago
(03-Jan-2025)

3/3 (100%)

$-1.62 (-21.26%)

12

Show more analysts

Please expand the browser size to see the chart

What is LFCR (Lifecore Biomedical) average time for price targets to be met?

On average it took 133 days for the stock forecasts to be reached, with an average price target met ratio of 66.02%.

Which analyst most recently updated their price target on LFCR (Lifecore Biomedical)?

Michael Petusky

Which analyst has the most public recommendations on LFCR (Lifecore Biomedical)?

Michael Petusky works at BARRINGTON and has 51 price targets and 35 ratings on LFCR

Which analyst is the currently most bullish on LFCR (Lifecore Biomedical)?

Matt Hewitt with the highest potential upside of $4.83

Which analyst is the currently most reserved on LFCR (Lifecore Biomedical)?

Jacob Johnson with the lowest potential downside of -$0.39
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?